Cidara Therapeutics, Inc. (CDTX)
221.38
+0.06 (0.03%)
Inactive · Last trade price on Jan 6, 2026
Cidara Therapeutics Revenue
In the year 2024, Cidara Therapeutics had annual revenue of $1.28M, down -94.52%.
Revenue (ttm)
$1.28M
Revenue Growth
-94.52%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
38
Market Cap
6.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.28M | -22.01M | -94.52% |
| Dec 31, 2023 | 23.28M | -41.01M | -63.78% |
| Dec 31, 2022 | 64.29M | 14.72M | 29.69% |
| Dec 31, 2021 | 49.57M | 37.51M | 310.81% |
| Dec 31, 2020 | 12.07M | -8.85M | -42.30% |
| Dec 31, 2019 | 20.92M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCDTX News
- 6 weeks ago - Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations - GlobeNewsWire
- 7 weeks ago - Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025 - Forbes
- 7 weeks ago - Merck expects over $5 billion commercial opportunity from Cidara's flu drug - Reuters
- 7 weeks ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
- 7 weeks ago - Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX - Business Wire
- 7 weeks ago - This Biotech's Stock Price More Than Doubled on Friday. Here's Why. - Investopedia
- 2 months ago - This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy - Market Watch
- 2 months ago - Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches - Invezz